RS BioTherapeutics, Inc. — Form C (Regulation Crowdfunding)
RS BioTherapeutics, Inc. of Cumberland, MD filed a Form C (Regulation Crowdfunding) with the SEC on 2024-04-29. Target raise $10K, up to $1.2M. Offered through StartEngine Capital, LLC.
Offering
- Filed: 2024-04-29
- Form: C
- Accession: 0001665160-24-000649
- Target amount: $10K
- Maximum amount: $1.2M
- Security type: Other
- Securities offered: 10,000
- Deadline: 2024-07-29
- Funding portal / intermediary: StartEngine Capital, LLC
- Intermediary file number: 007-00007
Issuer
- CIK: 0001932193
- Website: http://rsbiotherapeutics.com
- Legal status: Corporation
- Organized in: DE
- Incorporated: 2021-02-08
- Address: 157 Baltimore St. Suite 140, Cumberland, MD, 21502
- Employees: 5
Financials (as filed)
- Total assets (most recent): $31K
- Cash (most recent): $5K
- Net income (most recent): $-3.0M
- Net income (prior): $-2.1M
- Short-term debt: $1.1M
- Long-term debt: $10K
People (6)
| Name | Role | Location |
|---|
| Curtis Rhine | CFO | Cumberland, MD |
| Dustin Freas | Board Director | Hunt Valley, MD |
| Dean Hart | CEO | Cumberland, MD |
| Dean Hart | Chief Executive Officer | Cumberland, MD |
| Justin Molignoni | Chairman of the Board | Cumberland, MD |
| Curtis R Rhine | Chief Financial Officer | Cumberland, MD |
Reg CF filing history (4)
More